SERPINA1 is a direct estrogen receptor target gene and a predictor of survival in breast cancer patients

Of all breast cancer patients, about 70% are ER+ and 10% are ER+/HER2+. The ER+/HER2+ patients have a worse outcome compared to ER+/HER2- patients. Currently there is a lack of effective prognosis biomarkers for the prediction of outcome in ER+/HER2+ patients. Genome-wide differences in ER binding b...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Hei Jason, Li, Haiqing, Liu, Zheng, Yuan, Yate-Ching, Mortimer, Joanne, Chen, Shiuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694868/
https://www.ncbi.nlm.nih.gov/pubmed/26158350

Ejemplares similares

Ejemplares similares